Literature DB >> 29121751

Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.

Rocio Hinojar1, Covadonga Fernández-Golfín2, Ariana González-Gómez3, Luis Miguel Rincón2, Maria Plaza-Martin3, Eduardo Casas3, Ana García-Martín3, Mª Angeles Fernandez-Mendez4, Amparo Esteban4, Jose Julio Jimenez Nacher3, Jose Luis Zamorano2.   

Abstract

BACKGROUND: Interstitial fibrosis, myocardial fiber disarray and non-uniform shortening are common histological features of hypertrophic cardiomyopathy (HCM). The degree of LV hypertrophy and fibrosis are postulated to contribute to the impairment of myocardial shortening. Cardiovascular magnetic resonance myocardial (CMR) feature tracking (CMR-FT) has emerged as a robust method that provides quantitative measurements of myocardial deformation. Our aim was first to evaluate LV strain parameters in HCM by CMR-FT and their dependence on both functional parameters and late gadolinium enhancement (LGE); and secondly we sought to determine their association with major cardiovascular outcomes. METHODS AND
RESULTS: 74 patients with HCM and 75 controls subjects underwent a CMR study including LGE imaging. Global peak longitudinal, circumferential and radial systolic strain values (GLS, GCS, GRS) were measured by CMR-FT. A primary endpoint of all-cause mortality and secondary combined endpoint of hospital admission related to heart failure, lethal ventricular arrhythmias or cardiovascular death were defined. Patients with HCM showed attenuation of all LV strain values (p<0.001). Multivariate analysis showed that both LV hypertrophy and %of LGE were independent predictors of attenuated LV strains. All systolic LV strain parameters were impaired in patients with primary and secondary endpoints (follow up time: 25.6±9.9months, p<0.05 and p<0.01 respectively). Abnormal GLS, GCS and GRS were significantly associated with primary and secondary endpoints.
CONCLUSION: Both LV hypertrophy and fibrosis contribute to the impairment of LV myocardial mechanics in HCM. In this population, reduced LV strain is associated with poor cardiac outcomes, particularly cardiovascular mortality and HF.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29121751     DOI: 10.1016/j.ijcard.2017.07.087

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  21 in total

Review 1.  Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy.

Authors:  Chike C Nwabuo; Ramachandran S Vasan
Journal:  Curr Hypertens Rep       Date:  2020-02-03       Impact factor: 5.369

2.  Prognostic value of regional strain by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy.

Authors:  Xiaorong Chen; Jiangfeng Pan; Jiner Shu; Xiaoru Zhang; Limei Ye; Lin Chen; Yi Hu; Risheng Yu
Journal:  Quant Imaging Med Surg       Date:  2022-01

3.  Real-world clinical validity of cardiac magnetic resonance tissue tracking in primitive hypertrophic cardiomyopathy.

Authors:  Pierpaolo Palumbo; Francesco Masedu; Camilla De Cataldo; Ester Cannizzaro; Federico Bruno; Silvia Pradella; Francesco Arrigoni; Marco Valenti; Alessandra Splendiani; Antonio Barile; Andrea Giovagnoni; Carlo Masciocchi; Ernesto Di Cesare
Journal:  Radiol Med       Date:  2021-12-11       Impact factor: 3.469

Review 4.  State-of-the-art myocardial strain by CMR feature tracking: clinical applications and future perspectives.

Authors:  Jing Xu; Wenjing Yang; Shihua Zhao; Minjie Lu
Journal:  Eur Radiol       Date:  2022-02-24       Impact factor: 7.034

5.  Altered regional myocardial velocities by tissue phase mapping and feature tracking in pediatric patients with hypertrophic cardiomyopathy.

Authors:  Arleen Li; Alexander Ruh; Haben Berhane; Joshua D Robinson; Michael Markl; Cynthia K Rigsby
Journal:  Pediatr Radiol       Date:  2019-10-28

Review 6.  Cardiac magnetic resonance imaging in the evaluation of patients with hypertrophic cardiomyopathy.

Authors:  Juan Carlos Brenes; Adelina Doltra; Susanna Prat
Journal:  Glob Cardiol Sci Pract       Date:  2018-08-12

7.  Afterload dependence of right ventricular myocardial deformation: A comparison between tetralogy of Fallot and atrially corrected transposition of the great arteries in adult patients.

Authors:  Aleksandra Trzebiatowska-Krzynska; Eva Swahn; Lars Wallby; Niels Erik Nielsen; Carl Johan Carlhäll; Lars Brudin; Jan E Engvall
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

Review 8.  CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy.

Authors:  Laura Keil; Céleste Chevalier; Paulus Kirchhof; Stefan Blankenberg; Gunnar Lund; Kai Müllerleile; Christina Magnussen
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

9.  Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy.

Authors:  Bela Merkely; Hajnalka Vago; Zsofia Dohy; Liliana Szabo; Attila Toth; Csilla Czimbalmos; Rebeka Horvath; Viktor Horvath; Ferenc Imre Suhai; Laszlo Geller
Journal:  Int J Cardiovasc Imaging       Date:  2021-02-08       Impact factor: 2.357

10.  Up-regulation of miR-195 contributes to cardiac hypertrophy-induced arrhythmia by targeting calcium and potassium channels.

Authors:  Lina Xuan; Yanmeng Zhu; Yunqi Liu; Hua Yang; Shengjie Wang; Qingqi Li; Chao Yang; Lei Jiao; Ying Zhang; Baofeng Yang; Lihua Sun
Journal:  J Cell Mol Med       Date:  2020-05-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.